-
Sumitomo Pharma Presents Urology and Oncology Data at AUA 2024 Annual Meeting
07 May 2024 14:03 GMT
… receiving pharmacological treatment for benign prostatic hyperplasia–
MARLBOROUGH … the trial.
Vibegron …
About Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is … medications for the treatment of OAB. Discontinue GEMTESA in patients who develop …
-
One-Year Outcomes of Transurethral Treatment of Bladder Neck Stenosis Following Transurethral Resection of the Prostate. Results from a Large, Multicenter Series
07 May 2024 13:34 GMT
… ) years. The majority of patients developed BNS following bipolar TURP (95 … almost fourfold higher odds of developing post-operative incontinence in our … neck contracture following endoscopic treatment of benign prostatic hyperplasia. J Clin Med. 2021;10(13 …
-
Temple Health highlights new minimally invasive treatments for enlarged prostate
07 May 2024 11:13 GMT
… Hill Hospital.
Urinary symptoms develop when the prostate enlarges … correlation between the two.
Treatment usually begins with behavior … night is a problem.
Medication can also be used … signs or symptoms of benign prostatic hyperplasia, you should talk to …
-
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
07 May 2024 10:30 GMT
… to-head randomized controlled trial (RCT) study (IMPACT … to benign prostatic hyperplasia (BPH). It is indicated for the treatment of … vs. Medication in the Initial Treatment of BPH-Associated LUTS … Relations and Strategy Development
investor.relations@teleflex. …
-
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
06 May 2024 12:00 GMT
… for the treatment of symptomatic benign prostatic hyperplasia (BPH) at both … patients passing their trial of voids.
Secondary … urology. PROCEPT BioRobotics develops, manufactures and sells … focus on treating benign prostatic hyperplasia, or BPH. BPH is the …
-
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
06 May 2024 20:15 GMT
… medical device company that develops and markets customizable, … treat an unrivaled variety of prostate cancer and/or benign prostatic hyperplasia (“BPH … TACT 5-year clinical trial data, along with … invasive treatment of uterine fibroids and has FDA approval …
-
Enhancing Uroflow Variability Assessment with Remote Diagnostics
07 May 2024 11:41 GMT
The following is a summary of “Role of remote diagnostics to better assess uroflow variability: insights from combining at-home uroflows and frequency volume charts from 19,868 voids using a novel, handheld, cellular embedded device,” published in the …
-
Critical Insights From Veru Analyst Ratings: What You Need To Know
06 May 2024 13:18 GMT
… company with a drug development program for the treatment of metabolic diseases … in the late stage development of certain drugs for management of breast … products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom …
-
Minimally invasive interventions for lower urinary tract symptoms: What sits between medical therapy and transurethral resection of the prostate.
05 May 2024 17:28 GMT
… variety of medical and surgical treatment options available today for the … benign prostatic hyperplasia (BPH).
The aim of this paper is to highlight the various treatment … however, the treatment landscape is rapidly evolving with the development of minimally …
-
Butterfly Medical Welcomes Experienced Urology Executive to its Helm
04 May 2024 01:46 GMT
… in patients with BPH (Benign Prostatic Hyperplasia), is excited to … trial, through the FDA Investigational Device Exception process.
About BPH … of Drugs Commonly Used for the Treatment of … Benign Prostatic Hyperplasia; Zeng et al.; Frontiers in Pharmacology; …